Author:
Rioux William,Teare Adrian,Rider Nathan,Jones Stephanie,Ghosh S. Monty
Abstract
Abstract
Background
In response to the exacerbated rates of morbidity and mortality associated with the overlapping overdose and COVID-19 epidemics, novel strategies have been developed, implemented, operationalized and scaled to reduce the harms resulting from this crisis. Since the emergence of mobile overdose response services (MORS), two strategies have aimed to help reduce the mortality associated with acute overdose including staffed hotline-based services and unstaffed timer-based services. In this article, we aim to gather the perspectives of various key interest groups on these technologies to determine which might best support service users.
Methods
Forty-seven participants from various interested groups including people who use substances who have and have not used MORS, healthcare workers, family members, harm reduction employees and MORS operators participated in semi-structured interviews. Transcripts were coded and analyzed using a thematic analysis approach.
Results
Four major themes emerged regarding participant perspectives on the differences between services, namely differences in connection, perceived safety, privacy and accessibility, alongside features that are recommended for MORS in the future.
Conclusions
Overall, participants noted that individuals who use substances vary in their desire for connection during a substance use session offered by hotline and timer-based service modalities. Participants perceived hotline-based approaches to be more reliable and thus potentially safer than their timer-based counterparts but noted that access to technology is a limitation of both approaches.
Funder
Health Canada’s Substance Use and Addictions Program
Canadian Institutes of Health Research
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Public Health Agency of Canada. Opioid and stimulant related harms in Canada. [Internet]. 2022. Available from: https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/
2. Krausz RM, Westenberg JN, Meyer M, Choi F. The upcoming synthetic ultrapotent opioid wave as a foreseeable disaster. Lancet Psychiatry. 2022;9(9):699–700.
3. Hu K, Klinkenberg B, Gan WQ, Slaunwhite AK. Spatial-temporal trends in the risk of illicit drug toxicity death in British Columbia. BMC Public Health. 2022;22(1):2121.
4. Palis H, Bélair M, Hu K, Tu A, Buxton J, Slaunwhite A. Overdose deaths and the COVID -19 pandemic in British Columbia, Canada. Drug Alcohol Rev. 2022;41(4):912–7.
5. Rioux W. Defining terminology and outcome measures for evaluating digital and/or virtual drug overdose response technology: an international Delphi study. 2023 Jan 31 [cited 2023 Apr 20]. Available from: https://osf.io/un49f/
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献